Tags

Type your tag names separated by a space and hit enter

Oral contraceptives and cancer.
Arch Geschwulstforsch. 1986; 56(2):155-67.AG

Abstract

The use of combined oral contraceptives has been shown in a number of studies to alter a women's risk of developing some kinds of cancer. Specifically, a 50% reduction in the risk of both ovarian and endometrial cancer has been demonstrated. This protective effect appears to persist for some time after oral contraceptives are stopped. Combined oral contraceptives do not appear to effect substantially the overall risk of developing breast cancer, although some data suggest that selected subgroups of women may be at a greater risk of developing breast cancer if oral contraceptives are used at specific times in a woman's reproductive life, especially if used for long periods of time. However, the data are not entirely consistent on this issue. The effect of oral contraceptives on the risk of developing cervical cancer is also not entirely clear, although the data available suggest a slightly increased risk of intraepithelial cervical cancer with prolonged use of oral contraceptives.

Authors

No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

3518652

Citation

Holck, S, and K Ebeling. "Oral Contraceptives and Cancer." Archiv Fur Geschwulstforschung, vol. 56, no. 2, 1986, pp. 155-67.
Holck S, Ebeling K. Oral contraceptives and cancer. Arch Geschwulstforsch. 1986;56(2):155-67.
Holck, S., & Ebeling, K. (1986). Oral contraceptives and cancer. Archiv Fur Geschwulstforschung, 56(2), 155-67.
Holck S, Ebeling K. Oral Contraceptives and Cancer. Arch Geschwulstforsch. 1986;56(2):155-67. PubMed PMID: 3518652.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oral contraceptives and cancer. AU - Holck,S, AU - Ebeling,K, PY - 1986/1/1/pubmed PY - 1986/1/1/medline PY - 1986/1/1/entrez SP - 155 EP - 67 JF - Archiv fur Geschwulstforschung JO - Arch. Geschwulstforsch. VL - 56 IS - 2 N2 - The use of combined oral contraceptives has been shown in a number of studies to alter a women's risk of developing some kinds of cancer. Specifically, a 50% reduction in the risk of both ovarian and endometrial cancer has been demonstrated. This protective effect appears to persist for some time after oral contraceptives are stopped. Combined oral contraceptives do not appear to effect substantially the overall risk of developing breast cancer, although some data suggest that selected subgroups of women may be at a greater risk of developing breast cancer if oral contraceptives are used at specific times in a woman's reproductive life, especially if used for long periods of time. However, the data are not entirely consistent on this issue. The effect of oral contraceptives on the risk of developing cervical cancer is also not entirely clear, although the data available suggest a slightly increased risk of intraepithelial cervical cancer with prolonged use of oral contraceptives. SN - 0003-911X UR - https://www.unboundmedicine.com/medline/citation/3518652/Oral_contraceptives_and_cancer_ L2 - http://www.diseaseinfosearch.org/result/5395 DB - PRIME DP - Unbound Medicine ER -